| Literature DB >> 23369114 |
Kazem Naddafi1, Mohammad Sadegh Hassanvand, Masud Yunesian, Fatemeh Momeniha, Ramin Nabizadeh, Sasan Faridi, Akbar Gholampour.
Abstract
The aims of the present study were to provide quantitative data on the impact of air pollution on the health of people living in Tehran city, the most populated city of Iran. The approach proposed by the World Health Organization (WHO) was applied using the AirQ 2.2.3 software developed by the WHO European Centre for Environment and Health, Bilthoven Division. Concentrations of ozone, nitrogen dioxide, sulfur dioxide and particulate matter of aerodynamic diameter ≤ 10 μm (PM10) were used to assess human exposure and health impacts in terms of attributable proportion of the health outcome, annual number of excess cases of mortality for all causes, and cardiovascular and respiratory diseases. The annual average of PM10, SO2, NO2 and O3 in Tehran were 90.58, 89.16, 85 and 68.82 μg/m3, respectively. Considering short-term effects, PM10 had the highest health impact on the 8,700,000 inhabitants of Tehran city, causing an excess of total mortality of 2194 out of 47284 in a year. Sulfur dioxide, nitrogen dioxide and ozone caused about, respectively, 1458, 1050 and 819 excess cases of total mortality. Results indicate that the magnitude of the health impact estimated for the city of Tehran underscores the need for urgent action to reduce the health burden of air pollution.Entities:
Year: 2012 PMID: 23369114 PMCID: PMC3561072 DOI: 10.1186/1735-2746-9-28
Source DB: PubMed Journal: Iranian J Environ Health Sci Eng ISSN: 1735-1979
Figure 1Map of the study area and locations of monitoring stations (Monitoring S) with valid observations.
Relative risk (RR) with 95% confidence intervals (95% CI), and corresponding reference, implemented in AirQ 2.2.3 software and used for the health effect estimates
| Mortality | Total ICD-9-cmb <800 | 543.5 | 1.003 (1.002–1.005)e[ | 1.003 (1.002–1.004)c[ | 1.006 (1.004–1.008)d[ | 1.004 (1.003-1.0048) [ |
| Cardiovascular ICD-9-cm 390–459 | 231 | 1.005 (1.002–1.007)e[ | 1.004 (1.003–1.005)c[ | 1.009 (1.005–1.013)d[ | 1.008 (1.002-1.012) [ | |
| Respiratory ICD-9-cm 460–519 | 48.4 | 1.013 (1.007–1.015)e[ | - | 1.013 (1.005–1.020)d[ | 1.01 (1.006-1.014) [ | |
| Morbidity | HAf Respiratory Disease | 1260 | - | - | 1.008 (1.0048-1.0112) [ | - |
| HA COPDg | 101.4 | - | 1.0026 (1.0006-1.0044) [ | | 1.0044 (1–1.011) [ | |
| HA cardiovascular disease | 436 | - | - | 1.009 (1.006-1.013) [ | - | |
| Acute myocardial infarction | 132 | - | - | - | 1.0064 (1.0026-1.0101) [ | |
a Crude rate per 100,000 inhabitants.
b International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-cm).
c 1 h average.
d Daily average.
e 8 h “moving average”.
f Hospital admissions.
g Chronic obstructive pulmonary disease.
Summary of the concentrations of air pollutants, and meteorological variables, Tehran (2010–2011)
| PM10, Annual 24 h (μg/m3) | 90.58 (41.99) | 22.54 | 60.34 | 86.65 | 114.80 | 175.68 | 329.95 | 7 | 2438 |
| SO2, Annual 24 h (μg/m3) | 89.16 (29.27) | 45.47 | 69.24 | 84.47 | 101.60 | 161.45 | 313.27 | 10 | 3172 |
| NO2, Annual 24 h (μg/m3) | 85 (24.183) | 49.37 | 68.88 | 77.72 | 95.70 | 145.88 | 163.85 | 13 | 4115 |
| O3, Annual 8 h (μg/m3) | 68.82 (40.48) | 10.88 | 35.32 | 59.75 | 99.28 | 158.60 | 187.16 | 11 | 3530 |
| Temperature (°C) | 19.68 (9.87) | −5 | 10.69 | 21.10 | 28.92 | 38.12 | 42 | | 365 |
| Relative humidity (%) | 38.87 (16.45) | 6 | 27.82 | 34.23 | 48.70 | 62.84 | 100 | 365 |
No. Station: number of monitoring stations with valid observations.
No. days: number of days with valid observations.
Figure 2Percentage of days on which people in Tehran are exposed to different concentrations of (A) PM, (B) SO, (C) NOand (D) O.
Estimated attributable proportion (AP) expressed as percentage and number of excess cases in a year due to short-term exposure above 10 μg/mfor PM, SO, Oand NO
| Total mortality | PM10 | 4.6 (3.14-6) | 2194 (1486–2880) |
| SO2 | 3 (2.33-3.67) | 1458 (1102–1739) | |
| NO2 | 2.2 (1–2.93) | 1050 (705–1389) | |
| O3 | 1.73 (1.16-2.85) | 819 (549–1349) | |
| Cardiovascular mortality | PM10 | 6.8 (3.89-9.35) | 1367 (738–1916) |
| SO2 | 5.98 (1.56-8.7) | 1202 (315–1751) | |
| NO2 | 2.93 (2.22-3.64) | 591 (446–733) | |
| O3 | 2.85 (1.16-3.95) | 574 (233–794) | |
| Respiratory mortality | PM10 | 9.53 (3.89-13.95) | 402 (164–588) |
| SO2 | 7.73 (4.55-10) | 310 (192–422) | |
| O3 | 7 (3.4-8) | 299 (143–341) | |
| Hospital Admissions Cardiovascular Disease | PM10 | 6.8 (4.64-9.53) | 2580 (1760–3617) |
| Hospital Admissions Respiratory Disease | PM10 | 6.09 (3.74-8.32) | 6677 (4107–9126) |
| Hospital Admissions COPD | NO2 | 2.79 (0.3-6.64) | 247 (27–586) |
| O3 | 4.80 (2.52-7.09) | 424 (222–626) | |
| SO2 | 3.38 (0–8.04) | 298 (0–710) | |
| Acute Myocardial Infarction | SO2 | 4.84 (2.02-7.43) | 556 (233–854) |
| NO2 | 2.65 (1.12-5.97) | 305 (129–687) |
a Obtained using the lower and upper RR values.